High-quality human tissue samples have become the gold standard for biomedical research, and reliable access to such materials is an important resource for many companies. In addition, the rapid growth of translational research and personalized medicine has further increased the demand for human biological samples.
Biobanks and tissue suppliers have grown exponentially in response to this increased sample demand, and there is now a wide range of suppliers, from specialized disease-specific collections to commercial suppliers. For more information about biobank, you can click here now.
Image Source: Google
Biobanks have grown since the 1970s with a growth rate of 42% between 1990 and 1999 and a further growth rate of 36% in the last ten years.
However, there are still some tissues and disease areas that are very difficult to obtain, and the lack of industry standardization that results in inconsistent sample quality and clinical data.
For many researchers, this leads to the frustrating impossibility of obtaining high-quality human samples, and they have no choice but to design experiments on the tissues they can obtain instead of pursuing the most promising research.
It is clear that no biorepository can cover the range of samples required for research; In addition, as trends change, the demand for studies also changes.
Several biobanks entered strategic alliances to address this, but there is currently no industry-wide standardization. This need leads to a general trend towards harmonization and sharing of best practices between biobanks.
The increasing demand for samples, combined with difficulties in sample supply, is leading to new ways of working in the biobanking industry and the availability of “on-demand” samples is becoming apparent.